STAGE IIIC NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IIIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Precision radiation plus immunotherapy shows promise for tough lung cancers
Disease control CompletedThis study tested a new way to treat advanced lung cancer (stages IIB to IIIC) that cannot be removed with surgery. It combined precise, MRI-guided radiation with chemotherapy and an immunotherapy drug called durvalumab. The goal was to see if this approach is safe and helps cont…
Matched conditions: STAGE IIIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
New combo therapy tested for hard-to-treat lung cancer
Disease control CompletedThis early-stage study tested a new drug called ONO-7475 combined with the standard drug osimertinib in 78 people with advanced EGFR-mutant non-small cell lung cancer that could not be treated with radiation. The main goal was to check safety and find the right dose. Researchers …
Matched conditions: STAGE IIIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC